Circulating and Tissue Galectin-3 in Gastrointestinal Inflammation: Clinical Significance and Biomarker Potential

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• Galectins are β-galactoside-binding lectins involved in cell interactions.
• Galectin-3 (Gal-3) is multifunctional, found in cytoplasm, nucleus, cell surface, and extracellularly.
• Gal-3 influences immune regulation, fibrosis, and tissue remodeling in various diseases.

Purpose of the Study:

• To explore the role of Galectin-3 in inflammatory conditions.
• To investigate Gal-3's involvement in immune regulation, fibrosis, and tissue remodeling.
• To assess Gal-3 as a potential therapeutic target for inflammatory and fibrotic diseases.

Main Methods:

• Literature review of studies on Galectin-3.
• Analysis of Gal-3 expression and function in inflammatory cells (e.g., macrophages).
• Examination of Gal-3's role in specific diseases like IBD, NASH, and liver fibrosis.

Main Results:

• Gal-3 is implicated in activating the NLRP3 inflammasome, exacerbating intestinal inflammation in IBD.
• Gal-3 promotes fibrosis in liver diseases (PBC, autoimmune hepatitis) via fibroblast activation and ECM deposition.
• Upregulation of Gal-3 in hepatic stellate cells and macrophages contributes to liver fibrosis and inflammation.

Conclusions:

• Galectin-3 is a significant contributor to inflammation and fibrosis in various diseases.
• Targeting Gal-3 demonstrates potential for reducing fibrosis and inflammation.
• Gal-3 inhibition presents a promising therapeutic strategy for inflammatory and fibrotic disorders.